Cargando…

Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report

BACKGROUND: There is a trend towards hypofractionated stereotactic radiotherapy (RT) in prostate cancer to apply high single doses in a few fractions. Using the Cyberknife(®) robotic system multiple non-coplanar fields are usually given with a treatment time of one hour or more. We planned to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumila, Marcin, Mack, Andreas, Schneider, Uwe, Storelli, Fabrizio, Curschmann, Jürgen, Gruber, Günther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150956/
https://www.ncbi.nlm.nih.gov/pubmed/25142237
http://dx.doi.org/10.1186/1748-717X-9-186
_version_ 1782332972603539456
author Sumila, Marcin
Mack, Andreas
Schneider, Uwe
Storelli, Fabrizio
Curschmann, Jürgen
Gruber, Günther
author_facet Sumila, Marcin
Mack, Andreas
Schneider, Uwe
Storelli, Fabrizio
Curschmann, Jürgen
Gruber, Günther
author_sort Sumila, Marcin
collection PubMed
description BACKGROUND: There is a trend towards hypofractionated stereotactic radiotherapy (RT) in prostate cancer to apply high single doses in a few fractions. Using the Cyberknife(®) robotic system multiple non-coplanar fields are usually given with a treatment time of one hour or more. We planned to evaluate organ motion in this setting injecting a hydrogel spacer to protect the anterior rectal wall during treatment. METHODS: A 66 years old man with low risk prostate cancer was planned for robotic hypofractionated stereotactic RT. After implantation of fiducial markers and a hydrogel spacer a total dose of 36.25 Gy in 5 fractions was given to the planning target volume (clinical target volume + 3 mm). After each beam the corresponding data reporting on the intra-fractional movement were pre-processed, the generated log-files extracted and the data analysed according to different directions: left -right (LR); anterior - posterior (AP); inferior -superior (IS). Clinical assessments were prospectively done before RT start, one week after the end of treatment as well as 1, 6 and 12 months afterwards. Symptoms were documented using Common Toxicity and Adverse Events Criteria 4.0. RESULTS: Tolerability of marker and hydrogel implantation was excellent. A total of 284 non-coplanar fields were used per fraction. The total treatment time for all fields per fraction lasted more than 60 minutes. The detected and corrected movements over all 5 fractions were in a range of +/- 4 mm in all directions (LR: mean 0,238 – SD 0,798; AP: mean 0,450 – SD 1,690; and IS: mean 0,908 – SD 1,518). V36Gy for the rectum was 0.062 ccm. After RT, grade 1-2 intestinal toxicity and grade 1 genitourinarytoxicity occurred, but resolved completely after 10 days. On 1-, 6- and 12-months follow-up the patient was free of any symptoms with only slight decrease of erectile function (grade 1). There was a continuous PSA decline. CONCLUSIONS: Prostate movement was relatively low (+/- 4 mm) even during fraction times of more than 60 minutes. The hydrogel spacer might serve as a kind of stabilisator for the prostate, but this should be analysed in a larger cohort of patients.
format Online
Article
Text
id pubmed-4150956
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41509562014-09-03 Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report Sumila, Marcin Mack, Andreas Schneider, Uwe Storelli, Fabrizio Curschmann, Jürgen Gruber, Günther Radiat Oncol Case Report BACKGROUND: There is a trend towards hypofractionated stereotactic radiotherapy (RT) in prostate cancer to apply high single doses in a few fractions. Using the Cyberknife(®) robotic system multiple non-coplanar fields are usually given with a treatment time of one hour or more. We planned to evaluate organ motion in this setting injecting a hydrogel spacer to protect the anterior rectal wall during treatment. METHODS: A 66 years old man with low risk prostate cancer was planned for robotic hypofractionated stereotactic RT. After implantation of fiducial markers and a hydrogel spacer a total dose of 36.25 Gy in 5 fractions was given to the planning target volume (clinical target volume + 3 mm). After each beam the corresponding data reporting on the intra-fractional movement were pre-processed, the generated log-files extracted and the data analysed according to different directions: left -right (LR); anterior - posterior (AP); inferior -superior (IS). Clinical assessments were prospectively done before RT start, one week after the end of treatment as well as 1, 6 and 12 months afterwards. Symptoms were documented using Common Toxicity and Adverse Events Criteria 4.0. RESULTS: Tolerability of marker and hydrogel implantation was excellent. A total of 284 non-coplanar fields were used per fraction. The total treatment time for all fields per fraction lasted more than 60 minutes. The detected and corrected movements over all 5 fractions were in a range of +/- 4 mm in all directions (LR: mean 0,238 – SD 0,798; AP: mean 0,450 – SD 1,690; and IS: mean 0,908 – SD 1,518). V36Gy for the rectum was 0.062 ccm. After RT, grade 1-2 intestinal toxicity and grade 1 genitourinarytoxicity occurred, but resolved completely after 10 days. On 1-, 6- and 12-months follow-up the patient was free of any symptoms with only slight decrease of erectile function (grade 1). There was a continuous PSA decline. CONCLUSIONS: Prostate movement was relatively low (+/- 4 mm) even during fraction times of more than 60 minutes. The hydrogel spacer might serve as a kind of stabilisator for the prostate, but this should be analysed in a larger cohort of patients. BioMed Central 2014-08-20 /pmc/articles/PMC4150956/ /pubmed/25142237 http://dx.doi.org/10.1186/1748-717X-9-186 Text en © Sumila et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Sumila, Marcin
Mack, Andreas
Schneider, Uwe
Storelli, Fabrizio
Curschmann, Jürgen
Gruber, Günther
Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report
title Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report
title_full Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report
title_fullStr Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report
title_full_unstemmed Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report
title_short Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife(®) treatment for prostate cancer – a case report
title_sort long-term intra-fractional motion of the prostate using hydrogel spacer during cyberknife(®) treatment for prostate cancer – a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150956/
https://www.ncbi.nlm.nih.gov/pubmed/25142237
http://dx.doi.org/10.1186/1748-717X-9-186
work_keys_str_mv AT sumilamarcin longtermintrafractionalmotionoftheprostateusinghydrogelspacerduringcyberknifetreatmentforprostatecanceracasereport
AT mackandreas longtermintrafractionalmotionoftheprostateusinghydrogelspacerduringcyberknifetreatmentforprostatecanceracasereport
AT schneideruwe longtermintrafractionalmotionoftheprostateusinghydrogelspacerduringcyberknifetreatmentforprostatecanceracasereport
AT storellifabrizio longtermintrafractionalmotionoftheprostateusinghydrogelspacerduringcyberknifetreatmentforprostatecanceracasereport
AT curschmannjurgen longtermintrafractionalmotionoftheprostateusinghydrogelspacerduringcyberknifetreatmentforprostatecanceracasereport
AT grubergunther longtermintrafractionalmotionoftheprostateusinghydrogelspacerduringcyberknifetreatmentforprostatecanceracasereport